The Bee Sting That Was Not : An Unusual Case of Hymenoptera Anaphylaxis Averted in a Patient Treated with Omalizumab for Asthma
Joint Authors
Boyer, Nathan
Bennett, Steven
Slaughter, Evelyn M.
Source
Issue
Vol. 2014, Issue 2014 (31 Dec. 2014), pp.1-3, 3 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2014-08-11
Country of Publication
Egypt
No. of Pages
3
Main Subjects
Abstract EN
This paper presents a case of hymenoptera venom anaphylaxis averted by omalizumab, a monoclonal antibody to IgE antibody.
This case suggests a novel and unintentional effect of this therapy.
Currently omalizumab is only FDA approved for the treatment of moderate-persistent allergic asthma.
However case reports, such as ours have illustrated omalizumab’s efficacy in the treatment of a myriad immunologic and allergic diseases.
These outcomes have broadened the understanding of omalizumab’s complex mechanism of action.
American Psychological Association (APA)
Slaughter, Evelyn M.& Boyer, Nathan& Bennett, Steven. 2014. The Bee Sting That Was Not : An Unusual Case of Hymenoptera Anaphylaxis Averted in a Patient Treated with Omalizumab for Asthma. Case Reports in Medicine،Vol. 2014, no. 2014, pp.1-3.
https://search.emarefa.net/detail/BIM-448814
Modern Language Association (MLA)
Slaughter, Evelyn M.…[et al.]. The Bee Sting That Was Not : An Unusual Case of Hymenoptera Anaphylaxis Averted in a Patient Treated with Omalizumab for Asthma. Case Reports in Medicine No. 2014 (2014), pp.1-3.
https://search.emarefa.net/detail/BIM-448814
American Medical Association (AMA)
Slaughter, Evelyn M.& Boyer, Nathan& Bennett, Steven. The Bee Sting That Was Not : An Unusual Case of Hymenoptera Anaphylaxis Averted in a Patient Treated with Omalizumab for Asthma. Case Reports in Medicine. 2014. Vol. 2014, no. 2014, pp.1-3.
https://search.emarefa.net/detail/BIM-448814
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-448814
